These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Yue J; Peng RX; Yang J; Kong R; Liu J Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840 [TBL] [Abstract][Full Text] [Related]
6. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Grönhagen-Riska C; Hellstrom PE; Fröseth B Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874 [TBL] [Abstract][Full Text] [Related]
7. Liver enzyme disturbances during isoniazid chemoprophylaxis in children. Beaudry PH; Brickman HF; Wise MB; MacDougall D Am Rev Respir Dis; 1974 Nov; 110(5):581-4. PubMed ID: 4429254 [No Abstract] [Full Text] [Related]
8. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis. Linna O; Uhari M Eur J Pediatr; 1980 Sep; 134(3):227-9. PubMed ID: 6968680 [TBL] [Abstract][Full Text] [Related]
9. Association of isoniazid-metabolizing enzyme genotypes and isoniazid-induced hepatotoxicity in tuberculosis patients. Sotsuka T; Sasaki Y; Hirai S; Yamagishi F; Ueno K In Vivo; 2011; 25(5):803-12. PubMed ID: 21753138 [TBL] [Abstract][Full Text] [Related]
10. Isoniazid-associated hepatitis--serum enzyme determinations and histologic features. Lewis JE; Mello P; Knauer CM West J Med; 1975 May; 122(5):371-6. PubMed ID: 1130028 [TBL] [Abstract][Full Text] [Related]
11. Quinidine hepatotoxicity. A report of a case and review of the literature. Koch MJ; Seeff LB; Crumley CE; Rabin L; Burns WA Gastroenterology; 1976 Jun; 70(6):1136-40. PubMed ID: 1269875 [TBL] [Abstract][Full Text] [Related]
12. Child With a Serpinginous Structure in the Bowel. Lee M; Rees CA; Munden MM Ann Emerg Med; 2017 Nov; 70(5):e47-e48. PubMed ID: 29056220 [No Abstract] [Full Text] [Related]
13. Validity of serum glutamic oxalacetic transaminase determinations in isoniazid recipients. Bailey WC; Taylor SL; Samuels MS; Dascomb HE; Ziskind M; DeRouen TA Am Rev Respir Dis; 1973 Apr; 107(4):670-2. PubMed ID: 4697675 [No Abstract] [Full Text] [Related]
14. [Antitubercular chemoprevention: hepatotoxicity and therapeutic compliance]. Hortoneda Giménez M; Alfonso Sánchez JL; Cortés Vizcaíno C; Sabater Pons A An Med Interna; 1993 Dec; 10(12):587-9. PubMed ID: 8049323 [TBL] [Abstract][Full Text] [Related]
17. Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children. Martinez-Roíg A; Camí J; Llorens-Terol J; de la Torre R; Perich F Pediatrics; 1986 Jun; 77(6):912-5. PubMed ID: 3487069 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation in the rat livers induced by low dosage isoniazid treatment. Zhang B; Sun S; Shen L; Zu X; Chen Y; Hao J; Huang X; Feng F Environ Toxicol Pharmacol; 2011 Nov; 32(3):486-90. PubMed ID: 22004970 [TBL] [Abstract][Full Text] [Related]
19. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children]. Dieu MJ J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047 [No Abstract] [Full Text] [Related]
20. Letter: Disturbed hepatic function during isoniazid chemoprophylaxis. Levy SA Am Rev Respir Dis; 1973 Dec; 108(6):1452-3. PubMed ID: 4751738 [No Abstract] [Full Text] [Related] [Next] [New Search]